ArticleMolecular cancer therapeutics2021

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.

Alexander M A van der Wiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.